Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Cash from Financing Activities
Trinity Biotech PLC
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cash from Financing Activities
-$16m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-35%
|
|
Medtronic PLC
NYSE:MDT
|
Cash from Financing Activities
-$7B
|
CAGR 3-Years
-180%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-20%
|
|
STERIS plc
NYSE:STE
|
Cash from Financing Activities
-$133.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
-3%
|
See Also
What is Trinity Biotech PLC's Cash from Financing Activities?
Cash from Financing Activities
-16m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Cash from Financing Activities amounts to -16m USD.
What is Trinity Biotech PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-35%
Over the last year, the Cash from Financing Activities growth was -30%. The average annual Cash from Financing Activities growth rates for Trinity Biotech PLC have been -81% over the past three years , 1% over the past five years , and -35% over the past ten years .